EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation

Meng Chen, Tianyi Zhang, Sheng Yang iD, Yiru Niu, Yiling Ge, Zaozao Chen iD, Juan Zhang iD, Yuepu Pu, Zhongze Gu, Geyu Liang

Cells · 19.12.2025 · 15 (1) · 7

DOI: 10.3390/cells15010007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.12.2025. Verfasst von Meng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Organoids, Heart. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Key Research and Development Plan (Social Development) Project of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced cardiotoxicity (DICT) severely hampers drug development and threatens patient safety. Together with the growing global burden of cardiovascular disease, there is an urgent need to establish more predictive preclinical models. Recently, human pluripotent stem cell-derived cardiac organoids (hCOs) have emerged as a promising three-dimensional in vitro model, achieving significant progress in simulating the complex structure and function of the human heart. However, existing reviews predominantly focus on technical construction or specific applications, lacking an integrated discussion of pathological model construction and their use under evolving regulatory frameworks. This review distinguishes itself by proposing a novel, holistic framework that bridges “construction technology,” “pathological modeling,” and “application evaluation.” We systematically categorize and summarize three major strategies for building hCO-based pathological models: patient-specific, gene-edited, and microenvironment-modulated approaches. Furthermore, we highlight the unique advantages of hCOs in preclinical drug assessment and detail their cutting-edge applications in early DICT warning, metabolism-related safety evaluation, and personalized drug evaluation. Finally, we address current challenges, including maturation and standardization, and outline future directions involving integration with organ-on-a-chip technology and artificial intelligence. This review aims to provide a theoretical foundation and roadmap toward more reliable and human-relevant drug development paradigms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsHeartHumansDrug Evaluation, PreclinicalPluripotent Stem CellsAnimals

Stichwörter der Autor:innen

cardiac organoidsdrug evaluationpathological modelspreclinical studies

Autor:innen und Institutionen

  • Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.
  • Institute of Biomedical Devices (Suzhou), Southeast University, Suzhou 215163, China.
  • State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

ORCID-Profile: Sheng Yang, Zaozao Chen, Juan Zhang

Förderung

  • National Natural Science Foundation of China
  • the Key Research and Development Plan (Social Development) Project of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province, Major Project

Zitieren

APA

Chen, M., Zhang, T., Yang, S., Niu, Y., Ge, Y., Chen, Z., Zhang, J., Pu, Y., Gu, Z., & Liang, G. (2025). Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation. Cells, 15(1), 7. https://doi.org/10.3390/cells15010007

Vancouver

Chen M, Zhang T, Yang S, Niu Y, Ge Y, Chen Z, et al. Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation. Cells. 2025;15(1):7. doi:10.3390/cells15010007

BibTeX
@article{Chen2025,
  author = {Chen, Meng and Zhang, Tianyi and Yang, Sheng and Niu, Yiru and Ge, Yiling and Chen, Zaozao and Zhang, Juan and Pu, Yuepu and Gu, Zhongze and Liang, Geyu},
  title = {Human Cardiac Organoids: Advances and Prospects from Construction to Preclinical Drug Evaluation},
  journal = {Cells},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {7},
  doi = {10.3390/cells15010007}
}
Kostenlos starten →